Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma
Braz. j. med. biol. res; 49 (8), 2016
Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate of 5%. Biomarkers for the early detection of pancreatic cancer are urgently needed. Transforming growth factor-beta1 (TGF-β1) is elevated in the tissues and plasma of patients with PDAC. However, no studies systemically report p...
Biomarcadores de Tumor/sangre, Carcinoma Ductal Pancreático/sangre, Carcinoma Ductal Pancreático/diagnóstico, Estimación de Kaplan-Meier, Neoplasias Pancreáticas/sangre, Neoplasias Pancreáticas/diagnóstico, Neoplasias Pancreáticas/secundario, Pronóstico, Estudios Retrospectivos, Sensibilidad y Especificidad, Factor de Crecimiento Transformador beta1/sangre